LODOZ 2.5mg / 6.25mg tablets medication leaflet

C07BB07 bisoprolol + hydrochlorothiazide • Cardiovascular system | Beta blocking agents and thiazides | Beta blocking agents, selective, and thiazides

The combination of bisoprolol and hydrochlorothiazide is used to treat hypertension. Bisoprolol is a beta-blocker that reduces heart rate and blood pressure, while hydrochlorothiazide is a diuretic that helps eliminate excess water and salt from the body, thereby reducing blood volume.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Common side effects include dizziness, fatigue, nausea, and dry mouth. In rare cases, more severe adverse effects such as excessive blood pressure reduction, electrolyte imbalances, or allergic reactions may occur.

This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients with severe kidney failure or other chronic conditions should consult their doctor before starting treatment.

General data about LODOZ 2.5mg / 6.25mg

Substance: bisoprolol + hydrochlorothiazide

Date of last drug list: 01-06-2025

Commercial code: W66297003

Concentration: 2.5mg / 6.25mg

Pharmaceutical form: tablets

Quantity: 30

Product type: original

Price: 18.51 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: MERCK HEALTHCARE KGAA - GERMANIA

Holder: MERCK ROMANIA SRL - ROMANIA

Number: 9841/2017/03

Shelf life: 5 years

Concentrations available for bisoprolol + hydrochlorothiazide

10mg/6.25mg, 2.5mg/6.25mg, 5mg/6.25mg

Compensation lists for LODOZ 2.5mg / 6.25mg MERCK SHARP DOHME

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

18.51 RON

9.25 RON

9.26 RON